Voloridge Investment Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
275,771
-318,019
-54% -$3.35M 0.01% 826
2025
Q4
$6.98M Sell
593,790
-641,080
-52% -$6.92M 0.02% 677
2025
Q3
$9.53M Buy
1,234,870
+181,072
+17% +$1.27M 0.03% 556
2025
Q2
$7.7M Buy
+1,053,798
New +$8.5M 0.03% 630
2023
Q4
Sell
-42,213
Closed -$519K 1363
2023
Q3
$519K Sell
42,213
-210,231
-83% -$3.13M ﹤0.01% 1207
2023
Q2
$4.06M Sell
252,444
-135,621
-35% -$2.23M 0.02% 748
2023
Q1
$6.76M Sell
388,065
-72,225
-16% -$1.03M 0.03% 577
2022
Q4
$4.25M Sell
460,290
-203,592
-31% -$1.9M 0.02% 702
2022
Q3
$5.72M Sell
663,882
-419,627
-39% -$4.17M 0.03% 610
2022
Q2
$8.83M Buy
1,083,509
+524,580
+94% +$5.01M 0.05% 487
2022
Q1
$6.79M Buy
+558,929
New +$11.8M 0.04% 531
2021
Q3
Sell
-51,501
Closed -$2.33M 1787
2021
Q2
$2.33M Buy
51,501
+47,129
+1,078% +$2.09M 0.02% 937
2021
Q1
$211K Sell
4,372
-15,159
-78% -$789K ﹤0.01% 1315
2020
Q4
$1.05M Sell
19,531
-63,360
-76% -$2.86M 0.01% 954
2020
Q3
$3.06M Buy
82,891
+70,557
+572% +$2.62M 0.03% 580
2020
Q2
$382K Sell
12,334
-110,500
-90% -$3.06M ﹤0.01% 1084
2020
Q1
$3.39M Sell
122,834
-40,621
-25% -$1.22M 0.1% 226
2019
Q4
$4.78M Buy
163,455
+62,799
+62% +$1.5M 0.09% 278
2019
Q3
$1.93M Buy
100,656
+7,938
+9% +$186K 0.03% 460
2019
Q2
$2.03M Buy
92,718
+18,549
+25% +$407K 0.06% 320
2019
Q1
$1.52M Buy
+74,169
New +$1.29M 0.05% 357

Other funds holding NEO

Voloridge Investment Management's NEO Position: Q1 2026 in Review

Voloridge Investment Management reduced its NeoGenomics (NEO) stake by 54% in Q1 2026, selling an estimated $3.35M and leaving 275,771 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #826.

Voloridge Investment Management first reported a position in NEO in Q1 2019 and has held it in 21 quarters since. The position peaked at $9.53M in Q3 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Voloridge Investment Management held 275,771 shares of NeoGenomics worth $2.05M as of Q1 2026.
  • Voloridge Investment Management sold 318,019 NeoGenomics shares in Q1 2026, an estimated $3.35M.
  • NeoGenomics made up 0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #826 holding.
  • Voloridge Investment Management first reported a position in NeoGenomics in Q1 2019 and has held it in 21 quarters since.
  • Voloridge Investment Management's NeoGenomics position peaked at $9.53M in Q3 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.